Skip to content

Clinical trials

Phase 1/2 Kidney Failure, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Phase: Phase 1/2 Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20062
20071
20102
20114
20122
20132
201410
20154
20161
20172
20181
20191
20201
20212
20223
20233
20243
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting10
Unknown status8
Terminated5
Active, not recruiting4
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cedars-Sinai Medical Center4
Rockwell Medical Technologies, Inc.4
Mansoura University3
Stanley Jordan, MD2
United Therapeutics2
A.O.U. Città della Salute e della Scienza1
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1
Abu Dhabi Health Services Company1
Aevi Genomic Medicine, LLC, a Cerecor company1
Anesiva, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic58
Renal Insufficiency, Chronic10
Renal Insufficiency5
Anemia2
Carcinoma, Renal Cell2
Hyperphosphatemia2
Kidney Diseases2
Acidosis1
Arteriovenous Fistula1
Cardiovascular Diseases1

Trials

Showing 76 to 58 of 58. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.